Ethylacetamide → N-ethyl-N-({4-[3-(trifluoromethyl)-4,5,6,7-tetrahydro-1H-indazol-1-yl]phenyl}methyl)acetamide
Reaction equation
Cl[CH2:2][C:3]1[CH:8]=[CH:7][C:6]([N:9]2[C:17]3[CH2:16][CH2:15][CH2:14][CH2:13][C:12]=3[C:11]([C:18]([F:21])([F:20])[F:19])=[N:10]2)=[CH:5][CH:4]=1.[CH2:22]([NH:24][C:25](=[O:27])[CH3:26])[CH3:23]>>[CH2:22]([N:24]([CH2:2][C:3]1[CH:8]=[CH:7][C:6]([N:9]2[C:17]3[CH2:16][CH2:15][CH2:14][CH2:13][C:12]=3[C:11]([C:18]([F:21])([F:20])[F:19])=[N:10]2)=[CH:5][CH:4]=1)[C:25](=[O:27])[CH3:26])[CH3:23]Participants
3
Procedure
The title compound was prepared from 1-[4-(chloromethyl)phenyl]-3-(trifluoromethyl)-4,5,6,7-tetrahydro-1H-indazole and N-ethylacetamide using a similar procedure to that described for Description 15.
Sources & evidence
- ORD record
- ord-4ce03165cd53410a961e2a5e6ad702c7
- Source dataset
- uspto-grants-2010_01
- Patent number
- US07642256B2
Reaction notes
Loading…